Regeneron - IPNY https://ipny.com Tue, 30 Jul 2024 11:57:41 +0000 en-US hourly 1 https://wordpress.org/?v=7.0.2 https://ipny.com/wp-content/uploads/2021/01/cropped-favicon-32-32x32.png Regeneron - IPNY https://ipny.com 32 32 eHealthcare Leadership Awards Honors IPNY with a Distinction Award for Regeneron Campaign https://ipny.com/ehealthcare-leadership-awards-honors-ipny-a-distinction-award-for-regeneron-campaign/?utm_source=rss&utm_medium=rss&utm_campaign=ehealthcare-leadership-awards-honors-ipny-a-distinction-award-for-regeneron-campaign Wed, 09 Nov 2022 22:49:10 +0000 https://ipny.com/?p=156383
eHealthcare Leadership Awards 2022

IPNY is proud to announce winning a Distinction eHealthcare Leadership Award for their Regeneron campaign, Mono WHAT? (Taking Aim Against COVID) in the category, Best COVID-19 Pandemic Related Communications. This was the only award given in the Pharma or Medical Equipment Manufacturer category. The eHealthcare Leadership Awards recognize outstanding digital creative work in the healthcare industry.

The campaign was an effort to help curtail the devastating effects of the ongoing COVID-19 pandemic, Regeneron, manufacturer of a Monoclonal Antibody treatment, launched an unbranded campaign to help build broader awareness of Monoclonal Antibodies (mAbs) as a potentially lifesaving therapy among at-risk patients (i.e., those with specific underlying health issues that could compound a COVID diagnosis) and their friends/families. The campaign is focused on educating newly diagnosed at-risk patients to seek treatment immediately. Importantly, this was an unbranded initiative that did not mention Regeneron or its product by name.

There was a call to action on all the work that led to the Regeneron landing page, seektreatmentnow.com, which was taken down. The site linked to a government sponsored website that had a host of educational information about COVID-19.

The media buy skewed toward both an urban and ethnically diverse population since the incidence of COVID was highest in cities and among ethnic minorities. In addition to television, the campaign leveraged social/digital marketing and Spanish language radio.

The campaign proved to be an immediate success. After just 10 weeks, awareness of monoclonal antibody treatment jumped 10% nationally and the percentage of those who claimed they became aware of monoclonal antibody treatment through television advertising more than tripled. Among the key Hispanic target, awareness of monoclonal antibody treatment jumped by 70%.

The eHealthcare Leadership Awards are a leading award program that exclusively acknowledges the very best websites and digital communications of healthcare organizations (both large and small), online health companies, pharmaceutical/medical equipment firms, agencies/suppliers, and business improvement initiatives. These awards highlight the role of digital communications in achieving healthcare organizations’ business objectives.

The post eHealthcare Leadership Awards Honors IPNY with a Distinction Award for Regeneron Campaign first appeared on IPNY.

]]>
Fierce Pharma Marketing Awards Has Chosen The Finalists https://ipny.com/fierce-pharma-marketing-awards-has-chosen-the-finalists/?utm_source=rss&utm_medium=rss&utm_campaign=fierce-pharma-marketing-awards-has-chosen-the-finalists Wed, 20 Jul 2022 21:15:00 +0000 https://ipny.com/?p=156364

IPNY and Regeneron Medical Affairs Insights & Value are recognized for their COVID campaign.

Fierce Pharma Marketing Awards has named IPNY and Regeneron Medical Affairs Insights & Value as a finalist in the PharmaTV category for their Mono WHAT? (Taking Aim Against COVID) campaign work.

The winners will be announced at the Awards Gala taking place on the evening of October 19, 2022 at the Philadelphia Academy of Fine Arts, during the annual Digital Pharma East conference. The Awards Gala will be an evening of celebration to honor the individuals, teams and companies who are leading the way in pharmaceutical marketing and advertising. See the finalist list here.

FiercePharma is a leading industry publication that delivers breaking news and analysis about drug companies, the FDA and the broader pharma industry. They cover the pharma waterfront, from late-stage drug development through the entire lifecycle—tracking regulatory approvals, payer negotiations, manufacturing, marketing, patent fights, government investigations and regulation, M&A deals and beyond. It is complete life sciences coverage from preclinical research to market and beyond.

The post Fierce Pharma Marketing Awards Has Chosen The Finalists first appeared on IPNY.

]]>